CA
OLMA icon

Cliff Asness’s Olema Pharmaceuticals OLMA Stock Holding History

Cliff Asness’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978K Sell
78,161
-11,401
-13% -$153K ﹤0.01% 3014
2026
Q1 		$1.34M Buy
89,562
+8,395
+10% +$187K ﹤0.01% 2616
2025
Q4 		$2.03M Sell
81,167
-14
-0% -$249 ﹤0.01% 2123
2025
Q3 		$795K Sell
81,181
-1,694
-2% -$10.2K ﹤0.01% 2566
2025
Q2 		$353K Buy
82,875
+37,214
+82% +$166K ﹤0.01% 2778
2025
Q1 		$172K Buy
+45,661
New +$230K ﹤0.01% 2921
2024
Q3 		– Sell
-12,125
Closed -$131K – 2844
2024
Q2 		$131K Buy
12,125
+704
+6% +$7.63K ﹤0.01% 2470
2024
Q1 		$129K Buy
11,421
+640
+6% +$8.26K ﹤0.01% 2313
2023
Q4 		$151K Buy
10,781
+728
+7% +$9.78K ﹤0.01% 2247
2023
Q3 		$124K Buy
+10,053
New +$102K ﹤0.01% 2204
2022
Q3 		– Sell
-70,973
Closed -$289K – 2280
2022
Q2 		$289K Buy
70,973
+29,457
+71% +$93.4K ﹤0.01% 1874
2022
Q1 		$177K Buy
+41,516
New +$229K ﹤0.01% 2086

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Cliff Asness's OLMA Position: Q2 2026 in Review

Cliff Asness reduced its Olema Pharmaceuticals (OLMA) stake by 13% in Q2 2026, selling an estimated $153K and leaving 78,161 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

Cliff Asness first reported a position in OLMA in Q1 2022 and has held it in 12 quarters since. The position peaked at $2.03M in Q4 2025. 182 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Cliff Asness held 78,161 shares of Olema Pharmaceuticals worth $978K as of Q2 2026.
  • Cliff Asness sold 11,401 Olema Pharmaceuticals shares in Q2 2026, an estimated $153K.
  • Olema Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3014 holding.
  • Cliff Asness first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
  • Cliff Asness's Olema Pharmaceuticals position peaked at $2.03M in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.